Cardiovascular AI startup Corologic lands South Korea's TIPS grant, begins clinical trials
What's the deal? CorologicDealroom has a profile for this one. Try Dealroom →, a cardiovascular imaging AI startup, has been selected for TIPS, South Korea's government technology startup support programme run by the Ministry of SMEs and Startups. The selection, recommended by seed investor and TIPS operator Seoul National University Technology HoldingsDealroom has a profile for this one. Try Dealroom →, secures up to two years of government R&D funding.
The backstory: Spun out of a research team led by professor Kang Si-hyuk at Seoul National University Bundang Hospital's cardiology department in May, Corologic earlier raised seed funding from Kakao Ventures and Seoul National University Technology Holdings.
What's the product? Corologic's Angio-FILM uses AI-based video frame interpolation to restore cardiovascular imaging. It converts coronary angiography footage shot at 7.5 frames per second into roughly 15 frames per second within seconds, letting clinicians track vessels and devices continuously using fewer X-ray images.
Why it matters: Coronary angiography and interventions expose patients and staff to radiation. Lowering the frame rate cuts the dose but reduces image continuity. Corologic aims to reduce the dose area product (DAP) by 25-50% during procedures, with the underlying technology published in npj Digital Medicine .
Market positioning: Angio-FILM is an installed edge AI solution that links to existing hospital imaging systems without replacing angiography equipment. It is not tied to a specific device maker, so it can run across varied medical institutions.
What's next? The TIPS grant funds Angio-FILM's refinement and multi-institution clinical validation across hospitals and equipment makers. Corologic then plans to pursue Class 2 medical device approval from South Korea's Ministry of Food and Drug Safety, ISO 13485 certification, and US FDA 510(k) clearance in sequence.
What they're saying: "With the recent seed investment and the TIPS selection following Seoul National University Technology Holdings' recommendation, we've laid the foundation to begin clinical validation and regulatory approval of Angio-FILM in earnest," said chief executive officer Hwang Kyung-rae. (translated from Korean)
The signal: The round reflects growing investor appetite for AI tools that deliver direct safety benefits in the procedure room, not just diagnostic support — a push to embed AI into clinical workflows while reducing risk for patients and staff alike.
Read more: wowtale.net
Image credit: U.S. Navy Medicine
